Armel Poda

Biographic Data

ID7039469
NAMEArmel Poda
GIVEN NAMESArmel
FAMILY NAMEPoda
SIGNATUREPODA A
AFFILIATIONSNazi Boni University
ORCID0000-0002-7463-9179
VERIFIEDYes
TOTAL WORKS9
TOTAL CITATIONS0
WORKS AS AUTHOR9
WORKS AS EDITOR0
FIRST PUBLICATION YEAR2018
LATEST PUBLICATION YEAR2026
H-INDEX0

  • The implementation of tuberculosis preventive therapy in HIV care clinics in Africa, Asia and Latin America

    Open AccessRemo Schmutz, Nicolas Banholzer et al.ARTICLEBMJ Global Health2026

    INTRODUCTION: Towards the 'End TB Strategy' targets, the WHO recommends the provision of tuberculosis (TB) preventive therapy (TPT) for high-risk groups including people living with HIV (PLWH). 3 years after the release of the updated 2020 WHO guidelines, we investigated the implementation of TPT services at HIV clinics in low-income and middle-income countries (LMICs), focusing on TB screening, populations eligible for TPT and available TPT regi…

  • Living in Fear

    Open AccessNoelle A Benzekri, Astou Diagne et al.ARTICLEAIDS and Behavior2026

    Dedicated studies to understand and explore HIV-related stigma among PWH in Senegal are essential for the development and implementation of effective stigma reduction strategies. The goals of this study were to understand the current challenges confronted by newly diagnosed PWH in Senegal and to explore the manifestations of HIV-related stigma using a mixed methods approach. We conducted a convergent mixed methods study among participants ≥ 18 ye…

  • Characteristics, management and factors associated with poor outcomes in Covid-19 patients in Burkina Faso

    Open AccessAriane Mamguem Kamga, Samiratou Ouédraogo et al.ARTICLEFrontiers in Public Health2025

    Objectives: To assess treatment and identify predictive factors of worsening in COVID-19 patients. Methods: This study was ambispective (both prospective and retrospective) and part of a multidisciplinary, multicenter project designed to generate epidemiological, sociological and anthropological data about the COVID-19 epidemic in Burkina Faso. Medical records of patients admitted for COVID-19 at the hospitals of Ouagadougou and Bobo-Dioulasso fr…

  • Perceptions and management of diabetes and obesity among people living with HIV in Côte d’Ivoire

    Open AccessJean Jacques Koffi, Marie K Plaisy et al.ARTICLEBMC Public Health2025

    These results highlight the complexity surrounding the perceptions and management of T2DM and obesity among PLHIV in Abidjan, Côte d'Ivoire. In order to implement innovative and efficient intervention strategies to prevent and treat these metabolic conditions, cultural beliefs as well as socio-economic barriers must be addressed

  • Incidence of unintended pregnancies and pregnancy experience among adolescents living with perinatally-acquired HIV in West Africa

    Open AccessDésiré Lucien Dahourou, Clément Tisseron et al.ARTICLEBMC Public Health2025

    Registered with the Pan African Clinical Trials Registry on 13 February 2024 (reference no. PACTR202402863175053)

  • Availability of substance use screening and treatment within HIV clinical sites across seven geographic regions within the IeDEA consortium

    Open AccessKathryn E Lancaster, Melissa A Stockton et al.ARTICLEInternational Journal of Drug…2024

    Availability of screening and treatment for AUD/SUD in HIV care settings is limited, leaving a substantial gap for integration into ongoing HIV care. A critical understanding is needed of the multilevel implementation factors or feasible implementation strategies for integrating screening and treatment of AUD/SUD into HIV care settings, particularly for resource-constrained regions

  • Acceptability and feasibility of home and hospital follow-up in Burkina Faso and Guinea

    Open AccessMélanie Plazy, Marie‐Hélène Doucet et al.ARTICLEPLOS Global Public Health2023

    Patient experiences and perspectives on trial participation and follow-up may influence their compliance with research procedures or negatively impact their well-being. We aimed to explore the acceptability and feasibility of home-based and hospital-based follow-up modalities among COVID-19 patients enrolled in the ANTICOV ANRS COV33 Coverage-Africa trial in Burkina Faso and Guinea. The trial (2021–2022) evaluated the efficacy of treatments to pr…

  • Incidence and Predictors of Imported Cases of Covid-19 in Burkina Faso

    Open AccessMikaila Kaboré, Kongnimissom Apoline Sondo et al.ARTICLEFrontiers in Public Health2022

    BACKGROUND: To limit the spread of COVID-19 due to imported cases, Burkina Faso has set up quarantine measures for arriving passengers. We aimed to determine the incidence and predictors of imported cases of COVID-19 in Burkina Faso. METHODS: 2) platform. Cox regression was used to identify predictors of imported cases of COVID-19. RESULTS: Among 6,332 travelers who arrived in the study period, 173 imported cases (2.7%) were recorded. The inciden…

  • Secret intake of antiretroviral treatment and HIV-1 viremia in a public routine clinic in Burkina Faso

    Pauline Penot, Arsène Héma et al.ARTICLEAIDS Care2018

    In sub-Saharan Africa, where people living with HIV are frequently stigmatized, the intake of antiretroviral treatment (ART) remains a critical issue for many patients. Although the secret intake of ART may hinder the adherence to treatment, data on its specific impact on therapeutic effectiveness are lacking. We therefore assessed the association between secret intake of ART (i.e., hidden from family) and HIV-1 viremia among patients treated in …